The global gene therapy market is growing rapidly; it is estimated to be worth USD 2.6 billion in 2023 and is anticipated to reach USD 17.3 billion by 2035. It is expected to grow at a compounded annual growth rate (CAGR) of 17.3% during the forecast period.
The growth of the gene therapy market is mainly attributed to the increasing demand for tailored therapies to treat diseases that...
The global gene therapy market is estimated to grow from $2.4 billion in 2024 to $16.5 billion by 2035, representing a CAGR of 19.25% during the forecast period till 2035.
There has been a consistent upward trend in the consolidation activity within the gene therapy domain, growing at a CAGR of 22.22%, since 2015. This can be attributed to the rise in demand for gene therapies and...
The gene therapy market landscape has transformed significantly since the approval of the world’s first gene therapy, Gendicine®, in the early 2000’s. Ever since then, with the constant R&D efforts of the gene therapy companies and non-industry stakeholder, an increasing number of therapies have entered the gene therapy market.
The global gene therapy market is estimated to...